Replies to post #40070 on Bergamo Acquisition Corp. (BGMO)

[HighYieldInvestments]

VistaGen Therapeutics Board of Directors APPROVED RECENT TRANSACTION

Jon S. Saxe,
Chairman

Brian J. Underdown, Ph.D.,
Director

H. Ralph Snodgrass, Ph.D.,
Founder, President and Chief Scientific Officer

Shawn K. Singh, J.D.
Chief Executive Officer

Management Team

Shawn K. Singh, J.D.
Chief Executive Officer, Director

H. Ralph Snodgrass, Ph.D.
Founder, President and Chief Scientific Officer, Director

Jerrold D. Dotson, CPA
Acting Chief Financial Officer

A. Franklin Rice, MBA
VP of Corporate Development, Secretary

Scientific Advisory Board

Gordon Keller, Ph.D.
Chairman, Director, McEwen Centre for Regenerative Medicine, University Health Network
DIRECTOR'S OF VSTA APPROVED RECENT TRANSACTION LIKE IT OR NOT